These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8468724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer.
    Ho AD, Thaler J, Stryckmans P, Coiffier B, Luciani M, Sonneveld P, Lechner K, Rodenhuis S, Peetermans ME, deCataldo F.
    J Natl Cancer Inst; 1990 Sep 05; 82(17):1416-20. PubMed ID: 2388293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deoxycoformycin in the treatment of mature T-cell leukaemias.
    Dearden C, Matutes E, Catovsky D.
    Br J Cancer; 1991 Nov 05; 64(5):903-6. PubMed ID: 1931613
    [Abstract] [Full Text] [Related]

  • 7. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.
    Mercieca J, Matutes E, Dearden C, MacLennan K, Catovsky D.
    J Clin Oncol; 1994 Dec 05; 12(12):2588-93. PubMed ID: 7989933
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
    Hensel M, Villalobos M, Kornacker M, Krasniqi F, Ho AD.
    Clin Lymphoma Myeloma; 2005 Sep 05; 6(2):131-5. PubMed ID: 16231851
    [Abstract] [Full Text] [Related]

  • 10. Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
    Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.
    Ann Oncol; 1999 Dec 05; 10(12):1493-8. PubMed ID: 10643542
    [Abstract] [Full Text] [Related]

  • 11. Salvage chemotherapy with pentostatin in prolymphocytic leukemia.
    Pagano L, Ortu-La Barbera EO, Voso MT, Zollino M, Laurenti L, Marra R, Leone G.
    Haematologica; 1994 Dec 05; 79(6):542-5. PubMed ID: 7896214
    [Abstract] [Full Text] [Related]

  • 12. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
    Dillman RO, Mick R, McIntyre OR.
    J Clin Oncol; 1989 Apr 05; 7(4):433-8. PubMed ID: 2784491
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
    Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A, Morra E, Keating MJ.
    Cancer; 2003 Jan 01; 97(1):114-20. PubMed ID: 12491512
    [Abstract] [Full Text] [Related]

  • 14. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr 01; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F, Benboubker L, Gardembas M, Coiffier B, Divine M, Sebban C, Blanc M, Abgrall JF, Lederlin P, Harousseau JL, Blaise AM, Grosbois B, Morice P, Ghandour C, Castaigne S.
    Leukemia; 2003 Jan 01; 17(1):45-51. PubMed ID: 12529659
    [Abstract] [Full Text] [Related]

  • 16. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
    Nagai T, Izumi T, Noborio K, Takatoku M, Ohtsuki T, Machii T, Komatsu N, Ozawa K.
    Rinsho Ketsueki; 2002 Jul 01; 43(7):583-5. PubMed ID: 12229130
    [Abstract] [Full Text] [Related]

  • 17. Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD, Thaler J, Willemze R, Lauria F, Mandelli F, Stryckmans P, de Cataldo F, Baccarani M, Peetermans ME, de Witte T.
    Cancer Treat Rev; 1990 Sep 01; 17(2-3):213-5. PubMed ID: 2272036
    [No Abstract] [Full Text] [Related]

  • 18. Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series.
    Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock R.
    Cancer; 2004 Jan 15; 100(2):342-9. PubMed ID: 14716770
    [Abstract] [Full Text] [Related]

  • 19. Pentostatin (2'-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group.
    Monfardini S, Sorio R, Cavalli F, Cerny TH, Van Glabbeke M, Kaye S, Smyth JF.
    Oncology; 1996 Jan 15; 53(2):163-8. PubMed ID: 8604244
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience with 2'-deoxycoformycin.
    Catovsky D.
    Hematol Cell Ther; 1996 Dec 15; 38 Suppl 2():S103-7. PubMed ID: 9137963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.